Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance

Hedström, Erik LU orcid ; Markenroth Bloch, Karin LU orcid ; Bergvall, Erik LU ; Ståhlberg, Freddy LU and Arheden, Håkan LU (2010) In Journal of Cardiovascular Magnetic Resonance 12.
Abstract
Background: Quantitative blood flow and aspects of regional myocardial function such as myocardial displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since a gadolinium-based contrast agent is often used to measure myocardial infarct size, we sought to determine whether the contrast agent affects measurements of aortic flow and myocardial displacement and strain. Phase-contrast data pre and post contrast agent was acquired during free breathing using 1.5T PC-CMR. Results: For aortic flow and regional myocardial function 12 and 17 patients were analysed, respectively. The difference pre and post contrast agent was 0.03 +/- 0.16 l/min for cardiac output, and 0.1 +/- 0.5 mm for myocardial... (More)
Background: Quantitative blood flow and aspects of regional myocardial function such as myocardial displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since a gadolinium-based contrast agent is often used to measure myocardial infarct size, we sought to determine whether the contrast agent affects measurements of aortic flow and myocardial displacement and strain. Phase-contrast data pre and post contrast agent was acquired during free breathing using 1.5T PC-CMR. Results: For aortic flow and regional myocardial function 12 and 17 patients were analysed, respectively. The difference pre and post contrast agent was 0.03 +/- 0.16 l/min for cardiac output, and 0.1 +/- 0.5 mm for myocardial displacement. Linear regression for myocardial displacement (MD) after and before contrast agent (CA) showed MDpostCA = 0.95MD(preCA)+0.05 (r = 0.95, p < 0.001). For regional myocardial function, the contrast-to-noise ratios for left ventricular myocardial wall versus left ventricular lumen were pre and post contrast agent administration 7.4 +/- 3.3 and 4.4 +/- 8.9, respectively (p < 0.001). The contrast-to-noise ratios for left ventricular myocardial wall versus surrounding tissue were pre and post contrast agent administration -16.9 +/- 22 and -0.2 +/- 6.3, respectively (p < 0.0001). Conclusions: Quantitative measurements of aortic flow yield equal results both in the absence and presence of gadolinium contrast agent. The total examination time may thereby be reduced when assessing both viability and quantitative flow using PC-CMR, by assessing aortic flow post contrast agent administration. Phase-contrast information for myocardial displacement is also assessable both in the absence and presence of contrast agent. However, delineation of the myocardium may be difficult or impossible post contrast agent due to the lower image contrast. Acquisition of myocardial displacement should therefore be performed pre contrast agent using current PC-CMR sequences. (Less)
Please use this url to cite or link to this publication:
author
; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Cardiovascular Magnetic Resonance
volume
12
article number
70
publisher
BioMed Central (BMC)
external identifiers
  • wos:000285392600001
  • scopus:79952803894
  • pmid:21106081
ISSN
1097-6647
DOI
10.1186/1532-429X-12-70
language
English
LU publication?
yes
id
9b3c4681-96ca-432c-af04-f87b31da840b (old id 1771207)
date added to LUP
2016-04-01 10:27:39
date last changed
2023-01-02 04:43:04
@article{9b3c4681-96ca-432c-af04-f87b31da840b,
  abstract     = {{Background: Quantitative blood flow and aspects of regional myocardial function such as myocardial displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since a gadolinium-based contrast agent is often used to measure myocardial infarct size, we sought to determine whether the contrast agent affects measurements of aortic flow and myocardial displacement and strain. Phase-contrast data pre and post contrast agent was acquired during free breathing using 1.5T PC-CMR. Results: For aortic flow and regional myocardial function 12 and 17 patients were analysed, respectively. The difference pre and post contrast agent was 0.03 +/- 0.16 l/min for cardiac output, and 0.1 +/- 0.5 mm for myocardial displacement. Linear regression for myocardial displacement (MD) after and before contrast agent (CA) showed MDpostCA = 0.95MD(preCA)+0.05 (r = 0.95, p &lt; 0.001). For regional myocardial function, the contrast-to-noise ratios for left ventricular myocardial wall versus left ventricular lumen were pre and post contrast agent administration 7.4 +/- 3.3 and 4.4 +/- 8.9, respectively (p &lt; 0.001). The contrast-to-noise ratios for left ventricular myocardial wall versus surrounding tissue were pre and post contrast agent administration -16.9 +/- 22 and -0.2 +/- 6.3, respectively (p &lt; 0.0001). Conclusions: Quantitative measurements of aortic flow yield equal results both in the absence and presence of gadolinium contrast agent. The total examination time may thereby be reduced when assessing both viability and quantitative flow using PC-CMR, by assessing aortic flow post contrast agent administration. Phase-contrast information for myocardial displacement is also assessable both in the absence and presence of contrast agent. However, delineation of the myocardium may be difficult or impossible post contrast agent due to the lower image contrast. Acquisition of myocardial displacement should therefore be performed pre contrast agent using current PC-CMR sequences.}},
  author       = {{Hedström, Erik and Markenroth Bloch, Karin and Bergvall, Erik and Ståhlberg, Freddy and Arheden, Håkan}},
  issn         = {{1097-6647}},
  language     = {{eng}},
  publisher    = {{BioMed Central (BMC)}},
  series       = {{Journal of Cardiovascular Magnetic Resonance}},
  title        = {{Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance}},
  url          = {{http://dx.doi.org/10.1186/1532-429X-12-70}},
  doi          = {{10.1186/1532-429X-12-70}},
  volume       = {{12}},
  year         = {{2010}},
}